Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 210.00
+2.00 (0.96%)
Jun 24, 2026, 3:30 PM JST
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 3.46 billion as of June 24, 2026. Its market cap has increased by 30.00% in one year.
Market Cap
3.46B
Enterprise Value
3.48B
Revenue
13.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
210.00
Market Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 3.46B, a decrease of -64.57%. That is a compound annual growth rate of -4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 3.46B | -31.80% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSource | 5.87B |
| Noile-Immune Biotech | 5.12B |
| Chiome Bioscience | 5.05B |
| Kohjin Bio | 4.92B |
| PRISM BioLab Co.,LTD | 4.77B |
| Linical | 4.72B |
| TMS Co., Ltd. | 4.60B |
| D. Western Therapeutics Institute | 3.85B |